OIA
CORT icon

OneDigital Investment Advisors’s Corcept Therapeutics CORT Stock Holding History

OneDigital Investment Advisors’s Portfolio CORT Stock Details CORT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-3,000
Closed -$33K – 670
2019
Q2 		$33K Hold
3,000
– – ﹤0.01% 656
2019
Q1 		$35K Buy
+3,000
New +$37.3K 0.01% 573

Other funds holding CORT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
ISL
Ingalls & Snyder LLC New York $2.83B AUM 21.61% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

OneDigital Investment Advisors's CORT Position: Q3 2019 in Review

OneDigital Investment Advisors sold out of Corcept Therapeutics (CORT) in Q3 2019, closing a stake of 3,000 shares — an estimated $33K sold.

OneDigital Investment Advisors first reported a position in CORT in Q1 2019 and held it in 2 quarters. The position peaked at $35K in Q1 2019. 193 funds tracked by Wall St. Rank hold CORT as of Q3 2019.

  • OneDigital Investment Advisors reported no remaining Corcept Therapeutics position as of Q3 2019 after selling out during the quarter.
  • OneDigital Investment Advisors sold 3,000 Corcept Therapeutics shares in Q3 2019, an estimated $33K.
  • OneDigital Investment Advisors first reported a position in Corcept Therapeutics in Q1 2019 and held it in 2 quarters.
  • OneDigital Investment Advisors's Corcept Therapeutics position peaked at $35K in Q1 2019.
  • 193 funds tracked by Wall St. Rank held Corcept Therapeutics as of Q3 2019.

Based on OneDigital Investment Advisors's 13F filing for Q3 2019, filed 8 Nov 2019.